• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Elevated FGF-23 associated with recurrent cardiovascular events after acute coronary syndrome

byAngela ZhangandAnees Daud
April 25, 2018
in Cardiology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Elevated FGF-23 concentration was associated with increased risk of adverse cardiovascular (CV) outcomes, including CV death and heart failure hospitalization.

2. Elevated FGF-23 was also associated with increased risk of all-cause mortality.

Evidence Rating Level: 2 (Good)

Study Rundown: Fibroblast growth factor 23 (FGF-23) is a protein hormone that inhibits renal reabsorption of phosphate and activation of vitamin D. Elevated FGF-23 has previously been linked to adverse CV outcomes in patients without established CV disease and in those with stable coronary artery disease and preserved left-ventricular ejection fraction. This study examines the prognostic utility of FGF-23 in patients after a recent ACS. The authors find that the patients in the top quartile of FGF-23 concentrations had an elevated risk for CV death or heart failure hospitalization, as well as an increased risk of all-cause mortality, CV death, MI, stroke, and atrial fibrillation. The association with CV death or heart failure hospitalization was attenuated in women. Despite being observational in nature, this study reveals a potential biomarker of adverse CV outcomes that is separate from traditional CV biomarkers, and strengthens the association of elevated FGF-23 with cardiac remodeling, heart failure, and ischemic events.

Click to read the study, published in JAMA Cardiology

Relevant Reading: Elevated fibroblast growth factor-23 and risk of cardiovascular disease or mortality in the general population: a meta-analysis

In-Depth [retrospective cohort study]: In this study, the authors determined an association between FGF-23 concentrations and the risk of CV death or heart failure hospitalization in a cohort of 4947 patients from the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) trial. Patients in the top quartile of FGF-23 concentrations had a higher risk of CV death or heart failure hospitalization compared to patients in other quartiles (adjusted HR, 2.35; 95% CI, 1.82-3.02; p < 0.001). Additionally, those in the top quartile also had an increased risk of all-cause mortality, CV death, MI, stroke, and atrial fibrillation. In general, women had a higher baseline median FGF-23 concentration than men. In terms of the association with CV death or heart failure hospitalization, women had an attenuated association with FGF-23 (women: HR, 1.11; 95%, 0.70-1.76; p = 0.67; men: HR, 3.11; 95% CI, 2.29-4.22; p < 0.001).

RELATED REPORTS

Wellness Check: Exercise

Chlorthalidone is not superior to hydrochlorothiazide in preventing hypertension-related cardiovascular events

Team-based care with a clinical decision support system reduces cardiovascular risk factors in diabetic patients

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiovascular diseasegenetic factorsgenomics
Previous Post

2 Minute Medicine Rewind April 23, 2018

Next Post

Understanding in-hospital mortality after stroke in pediatric patients

RelatedReports

Few older adolescents meet recommended levels of physical activity
Wellness

Wellness Check: Exercise

February 2, 2023
Preterm birth associated with cardiovascular risk factors in adolescence
Cardiology

Chlorthalidone is not superior to hydrochlorothiazide in preventing hypertension-related cardiovascular events

January 4, 2023
Higher parental monitoring linked to safer sex in teens
Cardiology

Team-based care with a clinical decision support system reduces cardiovascular risk factors in diabetic patients

December 22, 2022
Population-based risk factors and geographical trends identified for vitiligo
Cardiology

The majority of FDA-approved drug trials recruit from low- and middle-income countries

December 9, 2022
Next Post
Computed tomography improves diagnostic certainty in the emergency department

Understanding in-hospital mortality after stroke in pediatric patients

Better UTI resolution with 5-day nitrofurantoin over single-dose fosfomycin

Radiation dose associated with increased heart disease in Hodgkin lymphoma survivors

Addition of ticagrelor to aspirin significantly increased graft patency after elective CABG

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Concordance of diagnosis of autism spectrum disorder made by pediatricians vs multidisciplinary specialist teams
  • Cystatin C-based equation without race or sex improves accuracy of GFR estimation
  • #VisualAbstract: Aldosterone synthase inhibition reduced systolic blood pressure in patients with treatment-resistant hypertension
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options